Publicaciones en colaboración con investigadores/as de University of Liège (14)

1997

  1. Determination rapide par immunodosage de l'hemoglobine glyquee sur sang capillaire comparee a une methode d'affinite pour le boronate et capture d'ions sur sang veineux

    Annales de Biologie Clinique, Vol. 55, Núm. 2, pp. 139-144

1996

  1. Assessment of residual insulin secretion in diabetic patients using the intravenous glucagon stimulatory test: Methodological aspects and clinical applications

    Diabetes and Metabolism, Vol. 22, Núm. 6, pp. 397-406

1995

  1. AMYLIN ISLET AMYLOID POLYPEPTIDE - BIOCHEMISTRY, PHYSIOLOGY, PATHOPHYSIOLOGY

    DIABETES & METABOLISM, Vol. 21, Núm. 1, pp. 3-25

1994

  1. MAGNESIUM ET DIABETE

    Revue Francaise d'Endocrinologie Clinique - Nutrition et Metabolisme

1989

  1. Lack of deleterious effects of the alpha1-adrenoceptor blocking agent doxazosin on insulin secretion and insulin sensitivity in healthy men

    Current Therapeutic Research - Clinical and Experimental, Vol. 46, Núm. 2, pp. 200-209

  2. Role of insulin and counter-regulatory hormones on the metabolic deterioration that follows insulin withdrawal in diabetic patients

    Revista Espanola de Fisiologia, Vol. 45, Núm. 1, pp. 53-59

1987

  1. The addition of glipizide to insulin therapy in Type-II diabetic patients with secondary failure to sulfonylureas is useful only in the presence of a significant residual insulin secretion

    Acta Endocrinologica, Vol. 116, Núm. 3, pp. 364-372

1985

  1. Insulin-stimulated glucose disposal is not increased in anorexia nervosa

    Journal of Clinical Endocrinology and Metabolism, Vol. 60, Núm. 2, pp. 311-314

1984

  1. Metabolic alterations after a two-hour nocturnal interruption of a continuous subcutaneous insulin infusion

    Diabetes Care, Vol. 7, Núm. 4, pp. 338-342

1983

  1. A 6-hour nocturnal interruption of a continuous subcutaneous insulin infusion: 1. Metabolic and hormonal consequences and scheme for a prompt return to adequate control

    Diabetologia, Vol. 24, Núm. 5, pp. 314-318

  2. A 6-hour nocturnal interruption of a continuous subcutaneous insulin infusion: 2. Marked attenuation of the metabolic deterioration by somatostatin

    Diabetologia, Vol. 24, Núm. 5, pp. 319-325

  3. Blood collection while using a continuous glucose analyzer without insertion of an additional venous catheter

    Diabetologia, Vol. 25, Núm. 2, pp. 120-122

  4. Circadian profiles of blood glucose and plasma free insulin during treatment with Semisynthetic and Biosynthetic human insulin, and comparison with conventional monocomponent preparations

    European Journal of Clinical Pharmacology, Vol. 25, Núm. 6, pp. 767-771

1982

  1. Influence of a somatostatin infusion on the metabolic alterations accompanying a 6-h nocturnal interruption of a continuous subcutaneous insulin infusion

    Diabetologia, Vol. 23, Núm. 2